A detailed history of Winslow Capital Management, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Winslow Capital Management, LLC holds 5,058,732 shares of EW stock, worth $467 Million. This represents 1.86% of its overall portfolio holdings.

Number of Shares
5,058,732
Holding current value
$467 Million
% of portfolio
1.86%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$72.54 - $95.56 $367 Million - $483 Million
5,058,732 New
5,058,732 $483 Million
Q4 2021

Feb 11, 2022

SELL
$106.37 - $130.68 $245 Million - $301 Million
-2,305,015 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$102.91 - $122.75 $105 Million - $125 Million
-1,020,308 Reduced 30.68%
2,305,015 $261 Million
Q2 2021

Aug 13, 2021

BUY
$83.84 - $104.76 $25.1 Million - $31.3 Million
298,794 Added 9.87%
3,325,323 $344 Million
Q1 2021

May 13, 2021

BUY
$78.68 - $90.67 $227 Million - $261 Million
2,878,877 Added 1949.77%
3,026,529 $253 Million
Q4 2020

Feb 12, 2021

BUY
$71.69 - $91.23 $10.6 Million - $13.5 Million
147,652 New
147,652 $13.5 Million
Q1 2019

May 14, 2019

SELL
$47.89 - $64.05 $63,214 - $84,546
-1,320 Closed
0 $0
Q4 2018

Feb 13, 2019

SELL
$46.41 - $56.94 $65.5 Million - $80.3 Million
-1,410,450 Reduced 99.91%
1,320 $202,000
Q3 2018

Nov 09, 2018

SELL
$45.7 - $58.03 $11.8 Million - $14.9 Million
-257,505 Reduced 15.43%
1,411,770 $246 Million
Q2 2018

Aug 13, 2018

SELL
$42.45 - $51.3 $13.9 Million - $16.7 Million
-326,441 Reduced 16.36%
1,669,275 $243 Million
Q1 2018

May 14, 2018

SELL
$37.19 - $47.45 $3.34 Million - $4.27 Million
-89,928 Reduced 4.31%
1,995,716 $278 Million
Q4 2017

Feb 12, 2018

BUY
$33.79 - $39.39 $15.5 Million - $18 Million
457,764 Added 28.12%
2,085,644 $235 Million
Q3 2017

Nov 14, 2017

BUY
$36.29 - $38.83 $59.1 Million - $63.2 Million
1,627,880
1,627,880 $178 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $57.1B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Winslow Capital Management, LLC Portfolio

Follow Winslow Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Winslow Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Winslow Capital Management, LLC with notifications on news.